Symptom Severity of Lyme Disease
Immune profile predicts whether Lyme clears easily after treatment—or turns chronic and debilitating. High-risk individuals benefit from early, aggressive treatment and immune support protocols rather than the "wait and see" approach that works fine for low-risk people.
What this measures
How your DNA shapes symptom severity of lyme disease.
Lyme disease severity and chronicity vary far more than the bacterial infection itself would predict — and a major piece of the variation tracks to HLA-DRB1 variants and the broader immune-response gene set. The genes shape how strongly the immune system mounts a response to Borrelia and its co-infections, and how readily that response converts into post-treatment chronic symptoms.
Carriers of specific HLA-DRB1 variants are associated with treatment-resistant or chronic Lyme presentations, even after standard antibiotic courses. Carriers of inflammatory-pathway variants (TNF, IL-6, IL-10) are associated with stronger systemic symptoms during acute infection. The same tick bite, the same antibiotic regimen, produces meaningfully different long-term trajectories.
Early detection and treatment remain the most effective interventions — most acute Lyme resolves cleanly with appropriate antibiotics when caught early. Co-infections (Babesia, Bartonella, Ehrlichia) often complicate the picture and warrant their own evaluation. Tick avoidance (treated outdoor gear, prompt tick checks, awareness of regional risk) remains the strongest prevention. Mitochondrial support, anti-inflammatory diet, and addressing co-infections all shape recovery trajectories in genetically susceptible carriers.
The same tick bite at the same time of year produces very different outcomes across people — and "Lyme didn't get better with the standard treatment" experiences track partly to immune-response variants that shape persistence. Which HLA-DRB1 pattern you carry decides how aggressively to pursue early treatment and what comprehensive recovery looks like beyond the antibiotic course.
Symptom Severity of Lyme Disease is one specific finding in this system. Your Genomic Lifestyle Optimization Report shows where your variants place you on the toxin sensitivities spectrum — and what you can do about it.
In your report
Where Symptom Severity of Lyme Disease lives inside your Genomic Lifestyle Optimization Report.
Symptom Severity of Lyme Disease renders as a dark-background card with a color marker calibrated to your specific variants. The card opens with the gene mechanism, shows your result at a glance via that marker, and closes with a practical, mechanism-led recommendation — what to eat, what to time, what cofactors to support.
Want to see what a real Mosaic dark card looks like? Walk through a sample report →
Questions people ask
About Symptom Severity of Lyme Disease.
- How does my DNA influence symptom severity of lyme disease?
- Why a scented candle is invisible to one nervous system and a four-hour headache for another. The TRPA1 receptor, the GST and NAT2 detox enzyme families, the HFE iron-loading variants, and the MTHFR methylation cycle together calibrate where your environmental tolerance threshold sits.
- What kind of test do I need to see my Symptom Severity of Lyme Disease result?
- Whole-genome sequencing at 30× clinical depth. Consumer SNP-chip tests like 23andMe or AncestryDNA only read ~0.02% of your DNA and miss most of the variants this analysis needs. Mosaic reads all 3 billion base pairs and produces the full 108-insight report.
- How is Symptom Severity of Lyme Disease different from clinical lab testing?
- Clinical labs measure downstream biomarkers — blood levels, hormone values, metabolic byproducts — at a single point in time. Genomic insights like Symptom Severity of Lyme Disease reveal the underlying variant that shapes the biology, which is constant for life. The two are complementary: labs show the current snapshot; genomics shows the long-term tendency and where lifestyle leverage is highest.
More from Toxin Sensitivities
toxin sensitivities
Heavy Metal Health Impact
Detox speed for mercury, lead, cadmium, and arsenic varies dramatically between people. Slow detoxers accumulate more from the same everyday exposure everyone gets—and benefit most from targeted chelation, prevention strategies, and cleaner sourcing.
Read insight →toxin sensitivities
Histamine Metabolism
DAO and HNMT enzymes break down histamine from wine, cheese, fermented foods, and leftovers. If yours run slow, you know exactly what happens—flushing, headaches, racing heart, or IBS symptoms within an hour of sushi. This confirms it's not "all in your head."
Read insight →toxin sensitivities
Histamine Production
Some immune systems overproduce histamine even without obvious allergens. This explains year-round congestion, itching, or hives that antihistamines only partly control—because you're constantly producing more than you can clear.
Read insight →toxin sensitivities
Histamine Receptor Function
Same histamine level, wildly different reaction. High receptor sensitivity turns normal amounts into hives, racing heart, or anxiety—even when production and breakdown are fine. The issue isn't how much histamine you have. It's how loudly your body hears it.
Read insight →toxin sensitivities
Histamine Transport Efficiency
Even with good breakdown enzymes, poor cellular export traps histamine inside cells, where it keeps causing problems. This variant explains widespread symptoms from tiny triggers that "shouldn't" bother anyone—and why even low-histamine diets don't fully work.
Read insight →toxin sensitivities
Inorganic Metal Processing Capacity
Lead from old pipes, cadmium from soil, and aluminum from cookware—your clearance rate for these common exposures varies. Slow processors benefit from better water filtration, periodic testing, and cookware upgrades. Fast processors have more natural resilience.
Read insight →
One test. 108 personalized findings. All yours.
Order your Mosaic kit. Receive your raw genomic data and the full Genomic Lifestyle Optimization Report in 15–20 days.